Solitary Flat Bone Metastasis of Follicular Thyroid Carcinoma: Complete Molecular and Partial Structural Response After 2 131 I Therapies.

J Nucl Med TechnolSep 3, 2026 (epub)

Rangat Bagasariya, Priyanka Verma, Sandip Basu

✦ AI-curated · Sources linked

Case in brief

A patient with follicular thyroid carcinoma presented with a solitary metastasis in the right iliac bone, which remained structurally unchanged after two high-dose 131 I therapies. Despite the persistence of the lesion, it exhibited no uptake on various imaging modalities, indicating a lack of metabolic activity. This case underscores the importance of molecular imaging in evaluating treatment response.

What made this case unusual

The lesion's structural persistence contrasted with its lack of metabolic activity on multiple imaging techniques, highlighting a significant discordance.

Diagnostic / clinical pearl

Clinicians should consider the role of molecular imaging in assessing treatment response, particularly when structural lesions remain unchanged.

Why it matters

This case emphasizes the need for integrating molecular imaging into the evaluation of differentiated thyroid carcinoma to better inform management decisions.

Source

Published in J Nucl Med Technol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.